Följ
Mikael Palner
Mikael Palner
Clinical Physiology and Nuclear Medicine, Dept. of Clinical Research, University of Southern Denmark
Verifierad e-postadress på health.sdu.dk - Startsida
Titel
Citeras av
Citeras av
År
Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport
S Syvänen, Ö Lindhe, M Palner, BR Kornum, O Rahman, B Långström, ...
Drug metabolism and disposition 37 (3), 635-643, 2009
3822009
Semiconducting polymer nanoparticles with persistent near‐infrared luminescence for in vivo optical imaging
M Palner, K Pu, S Shao, J Rao
Angewandte Chemie 127 (39), 11639-11642, 2015
1932015
Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers
A Ettrup, M Hansen, MA Santini, J Paine, N Gillings, M Palner, S Lehel, ...
European journal of nuclear medicine and molecular imaging 38, 681-693, 2011
1312011
Positron emission tomography imaging of drug‐induced tumor apoptosis with a caspase‐triggered nanoaggregation probe
B Shen, J Jeon, M Palner, D Ye, A Shuhendler, FT Chin, J Rao
Angewandte Chemie International Edition 52 (40), 10511-10514, 2013
1092013
Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET
A Ettrup, M Palner, N Gillings, MA Santini, M Hansen, BR Kornum, ...
Journal of Nuclear Medicine 51 (11), 1763-1770, 2010
582010
11C-NS14492 as a novel PET radioligand for imaging cerebral α7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements
A Ettrup, JD Mikkelsen, S Lehel, J Madsen, EØ Nielsen, M Palner, ...
Journal of Nuclear Medicine 52 (9), 1449-1456, 2011
562011
Preclinical kinetic analysis of the caspase-3/7 PET tracer 18F-C-SNAT: quantifying the changes in blood flow and tumor retention after chemotherapy
M Palner, B Shen, J Jeon, J Lin, FT Chin, J Rao
Journal of Nuclear Medicine 56 (9), 1415-1421, 2015
512015
Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET
MM Herth, V Kramer, M Piel, M Palner, PJ Riss, GM Knudsen, F Rösch
Bioorganic & medicinal chemistry 17 (8), 2989-3002, 2009
482009
Preclinical Safety Assessment of the 5-HT2A Receptor Agonist PET Radioligand [11C]Cimbi-36
A Ettrup, S Holm, M Hansen, M Wasim, MA Santini, M Palner, J Madsen, ...
Molecular imaging and biology 15, 376-383, 2013
462013
The Chemogenetic Receptor Ligand Clozapine N-Oxide Induces in vivo Neuroreceptor Occupancy and Reduces Striatal Glutamate Levels
S Bærentzen, A Casado-Sainz, D Lange, V Shalgunov, IM Tejada, ...
Frontiers in Neuroscience 13, 187, 2019
412019
Synthesis, in vitro and in vivo evaluation of [11C] MMTP: a potential PET ligand for mGluR1 receptors
J Prabhakaran, VJ Majo, MS Milak, SA Kassir, M Palner, L Savenkova, ...
Bioorganic & medicinal chemistry letters 20 (12), 3499-3501, 2010
392010
Synthesis and binding studies of 2-arylapomorphines
K Søndergaard, JL Kristensen, M Palner, N Gillings, GM Knudsen, ...
Organic & biomolecular chemistry 3 (22), 4077-4081, 2005
362005
In vivo assessment of behavioral recovery and circulatory exchange in the peritoneal parabiosis model
JM Castellano, M Palner, SB Li, GM Freeman Jr, A Nguyen, B Shen, ...
Scientific reports 6 (1), 29015, 2016
332016
Total synthesis and evaluation of [18F] MHMZ
MM Herth, F Debus, M Piel, M Palner, GM Knudsen, H Lüddens, F Rösch
Bioorganic & medicinal chemistry letters 18 (4), 1515-1519, 2008
332008
Molecular and functional imaging studies of psychedelic drug action in animals and humans
P Cumming, M Scheidegger, D Dornbierer, M Palner, BB Quednow, ...
Molecules 26 (9), 2451, 2021
272021
Further validation to support clinical translation of [18F]FTC-146 for imaging sigma-1 receptors
B Shen, ML James, L Andrews, C Lau, S Chen, M Palner, Z Miao, ...
EJNMMI research 5, 1-10, 2015
242015
Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in rats
A Casado-Sainz, F Gudmundsen, SL Baerentzen, D Lange, A Ringsted, ...
Neuropsychopharmacology 47 (2), 454-464, 2022
22*2022
Effects of unilateral 6-OHDA lesions on [3H]-N-propylnorapomorphine binding in striatum ex vivo and vulnerability to amphetamine-evoked dopamine release in rat
M Palner, C Kjaerby, GM Knudsen, P Cumming
Neurochemistry international 58 (3), 243-247, 2011
192011
The selective 5-HT2A receptor agonist 25CN-NBOH: structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H] 25CN-NBOH
AA Jensen, AL Halberstadt, E Märcher-Rørsted, AU Odland, M Chatha, ...
Biochemical Pharmacology 177, 113979, 2020
182020
Development of 18F-Labeled tetrazines for pretargeted imaging across the blood-brain barrier
V Shalgunov, SL van den Broek, I Andersen, RG Vázquez, N Raval, ...
Nuclear Medicine and Biology 108, S103-S104, 2022
16*2022
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20